SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086981
Filing Date
2023-11-14
Accepted
2023-11-14 16:20:38
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_cormedix.htm   iXBRL 10-Q 692458
2 CERTIFICATION f10q0923ex31-1_cormedix.htm EX-31.1 15869
3 CERTIFICATION f10q0923ex31-2_cormedix.htm EX-31.2 10753
4 CERTIFICATION f10q0923ex32-1_cormedix.htm EX-32.1 3734
5 CERTIFICATION f10q0923ex32-2_cormedix.htm EX-32.2 3854
  Complete submission text file 0001213900-23-086981.txt   4031223

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20230930.xsd EX-101.SCH 32375
7 XBRL CALCULATION FILE crmd-20230930_cal.xml EX-101.CAL 34561
8 XBRL DEFINITION FILE crmd-20230930_def.xml EX-101.DEF 192230
9 XBRL LABEL FILE crmd-20230930_lab.xml EX-101.LAB 372358
10 XBRL PRESENTATION FILE crmd-20230930_pre.xml EX-101.PRE 199484
42 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_cormedix_htm.xml XML 464164
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 231406688
SIC: 2834 Pharmaceutical Preparations